REFERENCES
  1. Said J, Cesarman E. Primary effusion lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2017.
  2. Campo E, Jaffe E et al. The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee. Blood, 2022.
  3. Nador RG, Cesarman E et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Ka- posi’s sarcoma-associated herpes virus. Blood 1996; 88:645–656.
  4. Hermine O, Michel M et al. Body-cavity-based lymphoma in an HIV-seronegative patient without Kaposi’s sarcoma-associated herpesvirus-like DNA sequences. N Engl J Med 1996;334:272–273.
  5. Alaggio R, Amador C, Anagnostopoulos I et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia, 2022; 36(7):1720-1748.
  6. Kaji D, Ota Y et al. Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis. Blood Adv. 2020 Sep 22;4(18):4442-4450.
  7. Kobayashi Y, Kamitsuji Y et al. Comparison of human herpes virus 8 related primary effusion lymphoma with human herpes virus 8 unrelated primary effusion lymphoma-like lymphoma on the basis of HIV: report of 2 cases and review of 212 cases in the literature. Acta Haematol. 2007;117(3):132-44.
  8. Ohshima K, Ishiguro M et al. Chromosomal and comparative genomic analyses of HHV-8-negative primary effusion lymphoma in five HIV-negative Japanese patients. Leuk Lymphoma. 2002 Mar;43(3):595-601.
  9. Alexanian S, J. Said J et al. KSHV/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states, Am J Surg Pathol. 2013;37:241–249.
  10. Shimada K, Hayakawa F et al. Biology and management of primary effusion lymphoma. Blood 2018; 132(18):1879–88.
  11. Loong F, CL Chan A et al. Diffuse large B-cell lymphoma associated with chronic inflammation as an incidental finding and new clinical scenarios. Modern Pathology. 2010; 23:493–501.
  12. Kubota T, Sasaki Y et al. Age and CD20 Expression Are Significant Prognostic Factors in Human Herpes Virus-8-negative Effusion-based Lymphoma. Am J Surg Pathol. 2018;42:1607-16.
  13. Terasaki Y, Yamamoto H et al. Disappearance of malignant cells by effusion drainage alone in two patients with HHV-8-unrelated HIV-negative primary effusion lymphoma-like lymphoma. Int J Hematol. 2011;94(3):279-284.
  14. Mendeville M, Roemer MGM et al. Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma. Blood. 2019;133(4):377-380.